<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0864-0289</journal-id>
<journal-title><![CDATA[Revista Cubana de Hematología, Inmunología y Hemoterapia]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cubana Hematol Inmunol Hemoter]]></abbrev-journal-title>
<issn>0864-0289</issn>
<publisher>
<publisher-name><![CDATA[Centro Nacional de Información de Ciencias MédicasEditorial Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0864-02892007000100005</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Anticuerpos naturales anti banda 3: Participan en el fenómeno de vasooclusión de la drepanocitosis]]></article-title>
<article-title xml:lang="en"><![CDATA[Natural anti-band 3 antibodies: Do they take part in the phenomenon of vasoocclusion drepanocytosis]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Villaescusa Blanco]]></surname>
<given-names><![CDATA[Rinaldo]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Arce Hernández]]></surname>
<given-names><![CDATA[Ada Amalia]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Merlín Linares]]></surname>
<given-names><![CDATA[Julio César]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Herrera Rolo]]></surname>
<given-names><![CDATA[Tania]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Espinosa Martínez]]></surname>
<given-names><![CDATA[Edgardo]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Instituto de Hematología eInmunología  ]]></institution>
<addr-line><![CDATA[Ciudad de La Habana ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2007</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2007</year>
</pub-date>
<volume>23</volume>
<numero>1</numero>
<fpage>0</fpage>
<lpage>0</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0864-02892007000100005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0864-02892007000100005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S0864-02892007000100005&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Se determinó la presencia de anticuerpos naturales anti banda 3 mediante un ensayo inmunoenzimático en microplacas acopladas con la proteína banda 3 en 14 pacientes con drepanocitosis, 4 con crisis vasooclusiva dolorosa y 10 en estado basal. Se demostró una disminución significativa (p = 0,000005) de los niveles de los anticuerpos naturales anti banda 3 en el total de los pacientes al compararlos con los controles normales, lo que puede estar relacionado con un consumo elevado de estos en el proceso de aclaramiento de eritrocitos con hemoglobina SS oxidados o senescentes. No se demostró diferencia estadística entre el grupo de pacientes en estado basal y aquellos con crisis vasooclusiva dolorosa, lo cual sugiere la posibilidad de que no haya participación de los anticuerpos naturales anti banda 3 en la modulación del fenómeno oclusivo que se produce en esta enfermedad. Se recomienda el estudio longitudinal de un número mayor de pacientes, que permita profundizar en este aspecto]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[The presence of natural anti-band 3 antibodies was determined by an immunoenzymatic assay in microplaques coupled with band 3 protein in 14 patients with drepanocytosis, 4 with painful vasoocclusive crisis and 10 in the basal state. It was proved a significant reduction (p = 0,000005) of the levels of natural anti-band 3 antibodies in all the patients on comparing them with the normal controls, which may be related to an elevated consumption of these in the clearance process of oxidized or senescent erythrocytes with hemoglobin SS. There was no statistical difference between the group of patients in the basal state and those with painful vasoocclusive crisis, which suggests that the natural anti-band 3 antibodies do not take part in the modulation of the occlusive phenomenon that is produced in this disease. The longitudinal study of a greater number of patients that allows to go deep into this apect is recommended]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[anticuerpos naturales anti banda 3]]></kwd>
<kwd lng="es"><![CDATA[crisis vasooclusiva dolorosa]]></kwd>
<kwd lng="es"><![CDATA[drepanocitosis]]></kwd>
<kwd lng="es"><![CDATA[proteína banda 3]]></kwd>
<kwd lng="en"><![CDATA[natural anti-band 3 antibodies]]></kwd>
<kwd lng="en"><![CDATA[painful vasoocclusive crisis]]></kwd>
<kwd lng="en"><![CDATA[drepanocytosis]]></kwd>
<kwd lng="en"><![CDATA[band 3 protein]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ Instituto de Hematolog&iacute;a e Inmunolog&iacute;a <h2>Anticuerpos naturales anti banda 3. &iquest;Participan en el fen&oacute;meno de vasooclusi&oacute;n de la drepanocitosis? </h2>     <p>DrC. Rinaldo Villaescusa Blanco, Lic. Ada Amalia Arce Hern&aacute;ndez, Lic. Julio C&eacute;sar Merl&iacute;n Linares, Lic. Tania Herrera Rolo y Dr. Edgardo Espinosa Mart&iacute;nez </p> <h4>Resumen </h4>     <p align="justify">Se determin&oacute; la presencia de anticuerpos naturales anti banda 3 mediante un ensayo inmunoenzim&aacute;tico en microplacas acopladas con la prote&iacute;na banda 3 en 14 pacientes con drepanocitosis, 4 con crisis vasooclusiva dolorosa y 10 en estado basal. Se demostr&oacute; una disminuci&oacute;n significativa (p = 0,000005) de los niveles de los anticuerpos naturales anti banda 3 en el total de los pacientes al compararlos con los controles normales, lo que puede estar relacionado con un consumo elevado de estos en el proceso de aclaramiento de eritrocitos con hemoglobina SS oxidados o senescentes. No se demostr&oacute; diferencia estad&iacute;stica entre el grupo de pacientes en estado basal y aquellos con crisis vasooclusiva dolorosa, lo cual sugiere la posibilidad de que no haya participaci&oacute;n de los anticuerpos naturales anti banda 3 en la modulaci&oacute;n del fen&oacute;meno oclusivo que se produce en esta enfermedad. Se recomienda el estudio longitudinal de un n&uacute;mero mayor de pacientes, que permita profundizar en este aspecto. </p>     <p><em>Palabras clave</em>:  anticuerpos naturales anti banda 3, crisis vasooclusiva dolorosa, drepanocitosis, prote&iacute;na banda 3. </p>     <p align="justify">La vasooclusi&oacute;n en la drepanocitosis se considera una caracter&iacute;stica &uacute;nica entre las anemias hemol&iacute;ticas y a&uacute;n cuando se han logrado avances en su conocimiento, las bases de su control y prevenci&oacute;n permanecen parcialmente desconocidas; no existe un mecanismo individual que explique este fen&oacute;meno. Recientemente, se ha establecido el papel del estr&eacute;s oxidativo, la activaci&oacute;n endotelial y la inflamaci&oacute;n en la vasooclusi&oacute;n, debido en parte al desarrollo de modelos murinos transg&eacute;nicos de la enfermedad.<span class="superscript">1-5</span> </p>     <p align="justify">Diversas investigaciones han permitido acumular informaci&oacute;n acerca de las mol&eacute;culas de adhesi&oacute;n, tanto en eritrocitos con hemoglobina SS (HbSS) como en el endotelio vascular, as&iacute; como factores plasm&aacute;ticos que participan en la vasooclusi&oacute;n. 6-10 En la actualidad se trabaja para establecer la posible participaci&oacute;n de la prote&iacute;na banda 3 eritrocitaria y los anticuerpos naturales anti banda 3 en el fen&oacute;meno de oclusi&oacute;n. </p>     <p align="justify">La banda 3 se refiere a una familia de intercambiadores ani&oacute;nicos (AE 0-3) presentes en la membrana de todas las c&eacute;lulas y organelos celulares.<span class="superscript">11-15</span> Bajo ciertas condiciones, la prote&iacute;na banda 3 de la membrana eritrocitaria (AE 1) se agrega en la superficie del eritrocito, lo que trae como consecuencia 2 cambios significativos: primero, estas c&eacute;lulas adquieren naturaleza adhesiva, y segundo, los agregados de banda 3 son reconocidos por anticuerpos naturales anti banda 3 como parte del mecanismo de aclaramiento de eritrocitos senescentes u oxidados.<span class="superscript">16,17</span> </p>     <p align="justify">Nuestro trabajo se encamin&oacute; a la determinaci&oacute;n de anticuerpos naturales anti banda 3 eritrocitaria, mediante un ensayo inmunoenzim&aacute;tico en un grupo de pacientes con drepanocitosis en estado basal y con crisis vasooclusivas dolorosas, con el objetivo de establecer la posible participaci&oacute;n de los mismos en el fen&oacute;meno de vasooclusi&oacute;n que se produce en esta enfermedad. </p> <h4>M&eacute;todos </h4>     <p align="justify">Se estudiaron 14 enfermos con el diagn&oacute;stico de drepanocitosis (pacientes SS), con una edad promedio de 31 a&ntilde;os y un rango entre 22 y 46 a&ntilde;os; 4 con crisis vasooclusivas dolorosas, sin s&iacute;ntomas ni signos de infecci&oacute;n u otras complicaciones cl&iacute;nicas y 10 en estado basal, sin manifestaciones cl&iacute;nicas en los 3 meses previos a la obtenci&oacute;n de la muestra. Ninguno de los enfermos recibi&oacute; transfusiones de gl&oacute;bulos rojos en los 3 meses anteriores al estudio. Se incluyeron 5 controles sanos con caracter&iacute;sticas similares a los de la muestra problema. Los sueros de pacientes y controles sanos se obtuvieron de muestras de sangre venosa, conserv&aacute;ndose a –70 &ordm;C hasta su uso. </p>     <p align="justify">Se determinaron los niveles de anticuerpos naturales anti banda 3 mediante un ensayo inmunoenzim&aacute;tico empleando banda 3 unida covalentemente a placas Chemobond. 18 Los sueros se diluyeron 1:400 con <em>buffer </em> GPBS (10 mM NaKHPO 4, 150 mM NaCl, 0,1 % gelatina, pH 7,4). Los sueros diluidos por triplicado (150 m L/pozo) se a&ntilde;adieron a las placas con la banda 3 inmovilizada incub&aacute;ndose 90 min a 37 &ordm;C. Los pozos se lavaron 3X con <em>buffer </em> GPBS conteniendo <em>Tween </em>20 al 0,05 %, y se incubaron a continuaci&oacute;n 1 h a 37 &ordm;C con un conjugado IgG-fosfatasa alcalina (Sigma, St. Louis, MI) 1:9000 (150 m L/pozo). Los pozos se lavaron 3X con GPBS- <em>Tween </em> 20 al 0,05 %, 3X con PBS y 1X con agua destilada. Se a&ntilde;adi&oacute; la soluci&oacute;n de sustrato, p-nitrofenil fosfato (pNPP, Sigma, St. Louis, MI), 150 m L/pozo, incub&aacute;ndose 1 h a 37 &ordm;C. Se midi&oacute; la absorbancia a 405 nm en un lector de microplacas PR – 521 (TecnoSUMA, Cuba). </p> <h4>Resultados </h4>     ]]></body>
<body><![CDATA[<p>En la tabla 1 se observa la diferencia estad&iacute;stica obtenida (p =,.0000006) al comparar los niveles de anticuerpos naturales anti banda 3 en el total de pacientes con drepanocitosis y los controles sanos. </p>     <p align="center">Tabla 1. Niveles de anticuerpos naturales anti banda 3 en el suero de pacientes con drepanocitosis </p>     <div align="center">   <table width="200" border="2">     <tr>       <td>    <div align="center">Pacientes SS    <br>       (n = 14)</div></td>       <td>    <div align="center">Controles sanos     <br>       (n = 5) </div></td>       <td>    <div align="center">p </div></td>     </tr>     <tr>       <td>    <div align="center">0,233 &plusmn; 0,068 </div></td>       <td>    <div align="center">0,473 &plusmn; 0,040</div></td>       <td>    ]]></body>
<body><![CDATA[<div align="center">0,0000006 </div></td>     </tr>   </table> </div>     <p align="center">&nbsp; </p>     <p>No se demostr&oacute; diferencia estad&iacute;stica al comparar los niveles de anticuerpos naturales anti banda 3 en los 2 grupos de pacientes con drepanocitosis estudiados (tabla 2). </p>     <p align="center">Tabla 2. Niveles de anticuerpos anti banda 3en el suero de pacientes con drepanocitosis en estado basal y con crisis vasooclusivas dolorosas (CVOD) </p>     <div align="center">   <table width="200" border="2">     <tr>       <td colspan="2">    <div align="center">Pacientes SS</div></td>       <td>&nbsp;</td>     </tr>     <tr>       <td>    <div align="center">Estado basal     <br>           (n = 10)</div></td>       <td>    <div align="center">CVOD    <br>           (n = 4) </div></td>       <td>    ]]></body>
<body><![CDATA[<div align="center">p </div></td>     </tr>     <tr>       <td>    <div align="center">0,248 &plusmn; 0,075 </div></td>       <td>    <div align="center">0,193 &plusmn; 0,024</div></td>       <td>    <div align="center">NS</div></td>     </tr>   </table> </div>     <p align="center">NS: no significativo. </p>     <p>En la figura se muestran los valores promedio y las desviaciones est&aacute;ndar en los pacientes con drepanocitosis en estado basal, crisis vasooclusivas dolorosas y controles sanos. </p>     <p align="center"><a href="/img/revistas/hih/v23n1/f0105107.jpg"><img src="/img/revistas/hih/v23n1/f0105107.jpg" width="282" height="231" border="0"></a></p>     
<div align="center">Figura. Niveles de anticuerpos naturales anti banda 3 en pacientes con drepanocitosis en estado basal, en crisis vasooclusiva dolorosa (CVOD) y en controles sanos. </div> <h4 align="center">Discusi&oacute;n </h4>     <p align="justify">En hemoglobinopat&iacute;as tales como la drepanocitosis, <span class="Estilo1">b</span> - talasemia y deficiencias de G6PD, existe un aumento de agregados de la prote&iacute;na banda 3 eritrocitaria, al compararlos con eritrocitos controles, como resultado de la oxidaci&oacute;n y desnaturalizaci&oacute;n posterior de la hemoglobina.<span class="superscript">19</span> Este fen&oacute;meno se describi&oacute; por primera vez en eritrocitos normales senescentes.<span class="superscript">20</span> La agregaci&oacute;n de la mol&eacute;cula banda 3, genera un olig&oacute;mero, el cual es reconocido por anticuerpos naturales de la clase IgG, lo que contrasta con la mayor&iacute;a de los anticuerpos de este tipo que son com&uacute;nmente de la clase IgM.<span class="superscript">20</span> Estas c&eacute;lulas a las que se une el anticuerpo, reaccionan con un componente del complemento C3b que acent&uacute;a su habilidad de ser reconocidas por el sistema fagoc&iacute;tico-mononuclear, y son eliminadas por los macr&oacute;fagos del bazo.<span class="superscript">21-23</span> </p>     <p align="justify">La participaci&oacute;n y especificidad de anticuerpos naturales anti banda 3, as&iacute; como de p&eacute;ptidos de banda 3 en el fen&oacute;meno de adhesi&oacute;n endotelial de eritrocitos infectados con el <em>Plasmodium falciparum </em> de la malaria, ha sido demostrado <em>in vitro </em> empleando c &eacute;lulas de melanoma y c&eacute;lulas endoteliales obtenidas de la vena umbilical humana.<span class="superscript">24,25</span> En un estudio realizado en ni&ntilde;os en &aacute;reas end&eacute;micas de malaria, se demostraron niveles elevados de anticuerpos naturales anti banda 3 en el grupo de alta infectaci&oacute;n, no as&iacute; en el de bajo nivel de infectaci&oacute;n, lo que sugiere su participaci&oacute;n en el aclaramiento de eritrocitos parasitados; el aumento de los anticuerpos anti banda 3 se correlacion&oacute; con la disminuci&oacute;n de la hemoglobina. (<em>Luginbuhl A</em>. Complement factor D, albumin and IgG anti band 3 naturally occurring antibodies mimic serum in rosetting of malaria-infected red blood cells. Tesis para optar por el Grado de Doctor en Ciencias Naturales. Swiss Federal Institute of Technology. Zurich. Switzerland, 2006). </p>     ]]></body>
<body><![CDATA[<p align="justify">En nuestro trabajo se obtuvieron bajos niveles de anticuerpos naturales anti banda 3 en el total de pacientes estudiados al compararlos con los controles sanos, lo que pudiera estar relacionado fundamentalmente con un consumo aumentado de los mismos en lo referente al aclaramiento de eritrocitos con HbSS oxidados. A&uacute;n cuando se observa cierta tendencia a la disminuci&oacute;n de los niveles de anticuerpos naturales anti banda 3 en el grupo con crisis vasooclusivas dolorosas, no se demostr&oacute; diferencia estad&iacute;stica al compararlos con los pacientes en estado basal, lo que sugiere que no haya participaci&oacute;n de los mismos en el fen&oacute;meno de oclusi&oacute;n en esta enfermedad. Resultar&iacute;a importante incrementar el n&uacute;mero de pacientes, as&iacute; como el estudio longitudinal de estos, que permita profundizar en dichos aspectos. </p> <h4 align="justify">Summary</h4> <h6>Natural anti-band 3 antibodies. Do they take part in the phenomenon of vasoocclusion drepanocytosis? </h6>     <p>The presence of natural anti-band 3 antibodies was determined by an immunoenzymatic assay in microplaques coupled with <strong></strong>band 3 <strong></strong>protein in 14 patients with drepanocytosis, 4 with painful vasoocclusive crisis and 10 in the basal state. It was proved a significant reduction (p = 0,000005) of the levels of natural anti-band 3 antibodies in all the patients on comparing them with the normal controls, which may be related to an elevated consumption of these in the clearance process of oxidized or senescent erythrocytes with hemoglobin SS. There was no statistical difference between the group of patients in the basal state and those with painful vasoocclusive crisis, which suggests that the natural anti-band 3 antibodies do not take part in the modulation of the occlusive phenomenon that is produced in this disease. The longitudinal study of a greater number of patients that allows to go deep into this apect is recommended. </p>     <p><em>Key words:</em> natural anti-band 3 antibodies, painful vasoocclusive crisis, drepanocytosis, band 3 protein. </p> <h4>Referencias bibliogr&aacute;ficas </h4>     <!-- ref --><p> 1. Nagel RL, Fabry ME. The panoply of animal models for sickle cell anemia. Br J Haematol 2001;112:19-25. <!-- ref --><p> 2. Belcher JD. Critical role of endothelial cell activation in hipoxia-induced vasooclusion in transgenic sickle mice. Am J Physiol Heart Circ Physiol 2005;288:H2715-25. <!-- ref --><p> 3. Mahaseth H. Polynitroxyl albumin inhibits inflammation and vasooclusion in transgenic sickle mice. J Lab Clin Med 2005;145:204-11. <!-- ref --><p> 4. Kaul DK, Hebbel RP. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest 2000;106:411-20. <!-- ref --><p> 5. Nagel RL. The challenge of painful crisis in sickle cell disease. JAMA 2001;286:2152-3. <!-- ref --><p> 6. Embury SH. The contribution of endothelial cell P-selectin to the microvascular flow of mouse sickle erythrocytes in vivo. Blood 2004;104:3378-85. <!-- ref --><p> 7. Kaul DK. Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice. Am J Physiol Heart Circ Physiol 2004;287:H293-H301. <!-- ref --><p> 8. Turhan A, Weiss LA, Mohandas N, Coller BS, Frenette PS. Primary role for adherent leukocytes in sickle cell vascular occlusion: A new paradigm. Proc Natl Acad Sci USA 2002;99:3047-51. <!-- ref --><p> 9. Setty BN, Stuart MJ. Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: Potential role in sickle cell disease. Blood 1996;88:2311-20. <!-- ref --><p> 10. Harlan JM. Introduction: anti-adhesion therapy in sickle cell disease. Blood 2000;95:365-7. <!-- ref --><p> 11. Kay MMB, Tracey CM, Goodman JR, Cone JC, Bassel PS. Polypeptides immunologically related to erythrocyte band 3 are present in nucleated somatic cells. Proc Natl Acad Sci USA 1983;80:1631-5. <!-- ref --><p> 12. Garlid K, Beavis A. Evidence for a existence of an inner membrane anion channel in mitochondria. Biochim Biophys Acta 1986;853:187-204. <!-- ref --><p> 13. Schuster VL, Bousib SM, Jennings ML. Two types of collecting duct mitochondria-rich (intercalated) cells: Lectin and band 3 cytochemistry. Am J Physiol 1986;251:C347-C55. <!-- ref --><p> 14. Kellokumpu S, Neff L, Jansa-Kellokumpu S, Kopito R, Baron RA. 115 kD polypeptide immunologically related to erythrocyte band 3 is present in Golgi membranes. Science 1988;242:1308-11. <!-- ref --><p> 15. Ruetz S, Lindsey AE, Ward CL, Kopito RR. Functional activation of plasma membrane anion exchangers occurs in a pre-Golgi compartment. Cell Biol 1993;121:37-48. <!-- ref --><p> 16. Thevenin BJ, Crandall I, Ballas SK. Band 3 peptides block the adherence of sickle cells to endothelial cells in vitro. Blood 1997;90:4172-9. <!-- ref --><p> 17. Hornig R, Lutz HU. Band 3 protein clustering on human erythrocytes promotes binding of naturally occuring anti - band 3 and anti – spectrin antibodies. Exp Geront 2000;35:1025-44. <!-- ref --><p> 18. Lutz HU, Stammler P, Fischer EA. Covalent binding of detergent-solubilized membrane glycoproteins to “Chemobond&quot; plates for ELISA. J Immunol Meth 1990;129:211-20. <!-- ref --><p> 19. Schluter K,, Dreuckhahn D. Co-clustering of denatured hemoglobin with band 3: Its role in binding of autoantibodies against band 3 to abnormal and aged erythrocytes. Proc Natl Acad Sci USA 1986;83:6137-41. <!-- ref --><p> 20. Lutz HU, Stringaro-Wipf G. Senescent red cell-bound IgG is attached to band 3 protein. Biomed Biochim Acta 1983;42:117-21. <!-- ref --><p> 21. Kay MMB, Goodman J. Immunoregulation of cellular lifespan: Physiologic autoantibodies and their peptide antigens. Cell Mol Biol 2003;49:217-43. <!-- ref --><p> 22. Kay MMB. Isolation of the phagocytosis inducing IgG-binding antigen on senescent somatic cells. Nature 1981;289:491-4. <!-- ref --><p> 23. Lutz HU, Stammler P, Fasler S. Preferential formation of C3b-IgG complexes in vitro and in vivo from nascent C3b and naturally occuring and band 3 antibodies. J Biol Chem 1993;268:17418-26. <!-- ref --><p> 24. Crandall I, Collins We, Gysin J, Sherman JW. Synthetic peptides based on motifs present in human band 3 protein inhibit cytoadherence/sequestration of the malaria parasite Plasmodium falciparum. Proc Natl Acad Sci USA 1993;90:4703-7. <!-- ref --><p> 25. Crandall I, Guthrie N, Sherman IW. Plasmodium falciparum: naturally occuring rabbit immunoglobulins recognized human band 3 motifs and malaria infected red cells. Exp Parasitol 1996;82:45-53.<p>Recibido: 22 de diciembre del 2006. Aprobado: 15 de enero del 2007.     <br> DrC. <em>Rinaldo Villaescusa Blanco</em>. Instituto de Hematolog&iacute;a eInmunolog&iacute;a.Apartado Postal 8070, Ciudad de La Habana, CP 10800, Cuba. Tel (537) 6438268, 6438695, 6434214, Fax (537) 442334. e -mail: <em></em><em><a href="mailto:ihidir@hemato.sld.cu">ihidir@hemato.sld.cu </a></em></p>     ]]></body>
<body><![CDATA[ ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nagel]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Fabry]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The panoply of animal models for sickle cell anemia]]></article-title>
<source><![CDATA[Br J Haematol]]></source>
<year>2001</year>
<volume>112</volume>
<page-range>19-25</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Belcher]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Critical role of endothelial cell activation in hipoxia-induced vasooclusion in transgenic sickle mice]]></article-title>
<source><![CDATA[Am J Physiol Heart Circ Physiol]]></source>
<year>2005</year>
<volume>288</volume>
<page-range>H2715-25</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mahaseth]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Polynitroxyl albumin inhibits inflammation and vasooclusion in transgenic sickle mice]]></article-title>
<source><![CDATA[J Lab Clin Med]]></source>
<year>2005</year>
<volume>145</volume>
<page-range>204-11</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kaul]]></surname>
<given-names><![CDATA[DK]]></given-names>
</name>
<name>
<surname><![CDATA[Hebbel]]></surname>
<given-names><![CDATA[RP]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice]]></article-title>
<source><![CDATA[J Clin Invest]]></source>
<year>2000</year>
<volume>106</volume>
<page-range>411-20</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nagel]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The challenge of painful crisis in sickle cell disease]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2001</year>
<volume>286</volume>
<page-range>2152-3</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Embury]]></surname>
<given-names><![CDATA[SH]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The contribution of endothelial cell P-selectin to the microvascular flow of mouse sickle erythrocytes in vivo]]></article-title>
<source><![CDATA[Blood]]></source>
<year>2004</year>
<volume>104</volume>
<page-range>3378-85</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kaul]]></surname>
<given-names><![CDATA[DK]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice]]></article-title>
<source><![CDATA[Am J Physiol Heart Circ Physiol]]></source>
<year>2004</year>
<volume>287</volume>
<page-range>H293-H301</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Turhan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Weiss]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Mohandas]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Coller]]></surname>
<given-names><![CDATA[BS]]></given-names>
</name>
<name>
<surname><![CDATA[Frenette]]></surname>
<given-names><![CDATA[PS]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Primary role for adherent leukocytes in sickle cell vascular occlusion: A new paradigm]]></article-title>
<source><![CDATA[Proc Natl Acad Sci USA]]></source>
<year>2002</year>
<volume>99</volume>
<page-range>3047-51</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Setty]]></surname>
<given-names><![CDATA[BN]]></given-names>
</name>
<name>
<surname><![CDATA[Stuart]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: Potential role in sickle cell disease]]></article-title>
<source><![CDATA[Blood]]></source>
<year>1996</year>
<volume>88</volume>
<page-range>2311-20</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Harlan]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Introduction: anti-adhesion therapy in sickle cell disease]]></article-title>
<source><![CDATA[Blood]]></source>
<year>2000</year>
<volume>95</volume>
<page-range>365-7</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kay]]></surname>
<given-names><![CDATA[MMB]]></given-names>
</name>
<name>
<surname><![CDATA[Tracey]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Goodman]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Cone]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Bassel]]></surname>
<given-names><![CDATA[PS]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Polypeptides immunologically related to erythrocyte band 3 are present in nucleated somatic cells]]></article-title>
<source><![CDATA[Proc Natl Acad Sci USA]]></source>
<year>1983</year>
<volume>80</volume>
<page-range>1631-5</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garlid]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Beavis]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Evidence for a existence of an inner membrane anion channel in mitochondria]]></article-title>
<source><![CDATA[Biochim Biophys Acta]]></source>
<year>1986</year>
<volume>853</volume>
<page-range>187-204</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schuster]]></surname>
<given-names><![CDATA[VL]]></given-names>
</name>
<name>
<surname><![CDATA[Bousib]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Jennings]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Two types of collecting duct mitochondria-rich (intercalated) cells: Lectin and band 3 cytochemistry]]></article-title>
<source><![CDATA[Am J Physiol]]></source>
<year>1986</year>
<volume>251</volume>
<page-range>C347-C55</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kellokumpu]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Neff]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Jansa-Kellokumpu]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kopito]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Baron]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[115 kD polypeptide immunologically related to erythrocyte band 3 is present in Golgi membranes]]></article-title>
<source><![CDATA[Science]]></source>
<year>1988</year>
<volume>242</volume>
<page-range>1308-11</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ruetz]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Lindsey]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Ward]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Kopito]]></surname>
<given-names><![CDATA[RR]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Functional activation of plasma membrane anion exchangers occurs in a pre-Golgi compartment]]></article-title>
<source><![CDATA[Cell Biol]]></source>
<year>1993</year>
<volume>121</volume>
<page-range>37-48</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thevenin]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
<name>
<surname><![CDATA[Crandall]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Ballas]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Band 3 peptides block the adherence of sickle cells to endothelial cells in vitro]]></article-title>
<source><![CDATA[Blood]]></source>
<year>1997</year>
<volume>90</volume>
<page-range>4172-9</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hornig]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Lutz]]></surname>
<given-names><![CDATA[HU]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Band 3 protein clustering on human erythrocytes promotes binding of naturally occuring anti - band 3 and anti - spectrin antibodies]]></article-title>
<source><![CDATA[Exp Geront]]></source>
<year>2000</year>
<volume>35</volume>
<page-range>1025-44</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lutz]]></surname>
<given-names><![CDATA[HU]]></given-names>
</name>
<name>
<surname><![CDATA[Stammler]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Fischer]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Covalent binding of detergent-solubilized membrane glycoproteins to &#8220;Chemobond" plates for ELISA]]></article-title>
<source><![CDATA[J Immunol Meth]]></source>
<year>1990</year>
<volume>129</volume>
<page-range>211-20</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schluter]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Dreuckhahn]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Co-clustering of denatured hemoglobin with band 3: Its role in binding of autoantibodies against band 3 to abnormal and aged erythrocytes]]></article-title>
<source><![CDATA[Proc Natl Acad Sci USA]]></source>
<year>1986</year>
<volume>83</volume>
<page-range>6137-41</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lutz]]></surname>
<given-names><![CDATA[HU]]></given-names>
</name>
<name>
<surname><![CDATA[Stringaro-Wipf]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Senescent red cell-bound IgG is attached to band 3 protein]]></article-title>
<source><![CDATA[Biomed Biochim Acta]]></source>
<year>1983</year>
<volume>42</volume>
<page-range>117-21</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kay]]></surname>
<given-names><![CDATA[MMB]]></given-names>
</name>
<name>
<surname><![CDATA[Goodman]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Immunoregulation of cellular lifespan: Physiologic autoantibodies and their peptide antigens]]></article-title>
<source><![CDATA[Cell Mol Biol]]></source>
<year>2003</year>
<volume>49</volume>
<page-range>217-43</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kay]]></surname>
<given-names><![CDATA[MMB]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Isolation of the phagocytosis inducing IgG-binding antigen on senescent somatic cells]]></article-title>
<source><![CDATA[Nature]]></source>
<year>1981</year>
<volume>289</volume>
<page-range>491-4</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lutz]]></surname>
<given-names><![CDATA[HU]]></given-names>
</name>
<name>
<surname><![CDATA[Stammler]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Fasler]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Preferential formation of C3b-IgG complexes in vitro and in vivo from nascent C3b and naturally occuring and band 3 antibodies]]></article-title>
<source><![CDATA[J Biol Chem]]></source>
<year>1993</year>
<volume>268</volume>
<page-range>17418-26</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Crandall]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Collins]]></surname>
<given-names><![CDATA[We]]></given-names>
</name>
<name>
<surname><![CDATA[Gysin]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sherman]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Synthetic peptides based on motifs present in human band 3 protein inhibit cytoadherence/sequestration of the malaria parasite Plasmodium falciparum]]></article-title>
<source><![CDATA[Proc Natl Acad Sci USA]]></source>
<year>1993</year>
<volume>90</volume>
<page-range>4703-7</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Crandall]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Guthrie]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Sherman]]></surname>
<given-names><![CDATA[IW]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Plasmodium falciparum: naturally occuring rabbit immunoglobulins recognized human band 3 motifs and malaria infected red cells]]></article-title>
<source><![CDATA[Exp Parasitol]]></source>
<year>1996</year>
<volume>82</volume>
<page-range>45-53</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
